DOJ Launches New Multi-Agency Task Force: What Healthcare Fraud Defendants Need to Know

The New Task Force: A Fundamental Shift in Federal Enforcement Strategy

In my 25 years as a federal prosecutor and now as a defense attorney, I have never seen an enforcement initiative as broad and well-resourced as the DOJ’s newly launched Healthcare Fraud Task Force. This is not simply another strike force; it is a permanent, multi-agency collaboration that formally integrates the FBI, HHS Office of Inspector General, the Drug Enforcement Administration, and the Centers for Medicare & Medicaid Services into a single operational unit. The explicit mandate is to use shared intelligence and real-time claims data to identify and prosecute healthcare fraud at an unprecedented scale. For defendants, this means the old days of slow, siloed investigations are over—you may now face a federal criminal investigation, a civil False Claims Act suit, and an administrative exclusion proceeding all running in parallel. The Task Force is authorized under the Attorney General’s directive citing 28 U.S.C. § 509, and it operates with the full force of the Health Care Fraud Prevention and Enforcement Action Team (HEAT) initiative, but with far greater data-sharing authority. This structural change requires defendants to rethink every aspect of their defense strategy from the moment they receive a subpoena or target letter.

Data Analytics and the “Pre-Indictment” Phase: How the Government Builds Its Case

The most dangerous weapon in the Task Force’s arsenal is its use of advanced data analytics, specifically through the Unified Data Analytics Platform (UDAP) that aggregates Medicare Part A, Part B, Part D, and Medicaid claims across all 50 states. In my experience, prosecutors used to rely on whistleblowers or patient complaints to trigger an investigation; now, the Task Force’s algorithms flag statistical outliers in billing patterns—such as a sudden spike in high-reimbursed CPT codes for a single provider—and automatically generate investigative leads. This means you could be under investigation for months before you receive any formal notice, and by that time, the government may already have a detailed financial profile of your practice. The Task Force also leverages the federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)) and the Stark Law (42 U.S.C. § 1395nn) as predicate offenses, meaning even a technical violation of a billing rule can be repackaged as a criminal conspiracy to defraud the government. I have seen cases where a provider who made a simple coding error was charged with wire fraud under 18 U.S.C. § 1343 because the government argued the error demonstrated “intentional ignorance” of compliance obligations. If you are a healthcare provider, your first line of defense is not a lawyer—it is a robust, contemporaneous compliance audit that can demonstrate good faith reliance on billing software or coding consultants.

Parallel Proceedings and the “Three-Headed Monster”: Criminal, Civil, and Administrative Exposure

One of the most alarming aspects of this new Task Force is its explicit strategy of pursuing parallel proceedings—criminal prosecution, civil False Claims Act liability, and administrative exclusion from federal healthcare programs—simultaneously. Under 31 U.S.C. § 3729, the government can seek treble damages and penalties of up to $27,018 per false claim, which in a high-volume practice can quickly reach tens of millions of dollars. Meanwhile, the HHS-OIG can impose permissive or mandatory exclusion under 42 U.S.C. § 1320a-7, effectively ending a provider’s ability to treat Medicare or Medicaid patients, often before the criminal case is even resolved. I have represented physicians who, upon receiving a civil investigative demand (CID) under the False Claims Act, mistakenly assumed they could “cooperate” and avoid criminal charges—only to be indicted six months later for obstruction under 18 U.S.C. § 1519 for altering documents after the CID was served. The Fifth Amendment privilege against self-incrimination is still fully available in these civil proceedings, but many defendants waive it inadvertently by producing documents or speaking with agents without counsel present. The key takeaway here is that you cannot treat a civil subpoena or an OIG letter as a minor administrative matter; it is often the first step in a coordinated criminal investigation, and any response must be carefully vetted by experienced federal criminal defense counsel.

Immediate Steps for Healthcare Providers Under Scrutiny: A Defense Attorney’s Roadmap

If you believe you are under investigation by this Task Force, your first and most critical step is to preserve all relevant documents and communications, but do not conduct your own internal investigation without counsel directing the effort. Under the attorney-client privilege and the work product doctrine, communications with your lawyer are protected, but internal emails or notes you create on your own are discoverable and can be used against you. Second, immediately suspend any billing practices that could be flagged as “outlier” patterns, even if you believe they are medically necessary, because the government will use continued billing after you become aware of an investigation as evidence of willful intent under 18 U.S.C. § 1347 (Health Care Fraud). Third, do not speak with agents from the FBI, HHS-OIG, or any Task Force member without counsel present—this is non-negotiable. I have seen countless defendants talk themselves into an indictment by trying to “explain” a billing pattern, only to make inconsistent statements that become the foundation of a perjury or false statement charge under 18 U.S.C. § 1001. Finally, begin documenting your compliance efforts immediately: retain copies of your compliance manuals, training records, and any third-party billing audits you have conducted. In my experience, a well-documented, good-faith compliance program is often the single most effective mitigating factor during both plea negotiations and sentencing under the U.S. Sentencing Guidelines § 8B2.1.

If you or your healthcare organization is under investigation by the DOJ’s new Healthcare Fraud Task Force, do not wait for an indictment to take action. The window for proactive, strategic defense is narrow, and the consequences of inaction—including criminal conviction, treble damages, and permanent exclusion from Medicare and Medicaid—are career-ending. I have spent over two decades on both sides of the federal criminal justice system, and I know how these Task Force investigations unfold from the inside. Contact my office today for a confidential, privileged consultation. We will review your billing data, assess your exposure under the Anti-Kickback Statute and False Claims Act, and develop a defense strategy that protects your liberty, your license, and your livelihood. Time is not on your side—call now.